Epidemiology of HER2-low breast cancer in Lithuania

被引：0
|
作者：
Cesas, A. [1 ]
Poskiene, L. [2 ]
Valkiuniene, R. B. [3 ]
Radvinskiene, L. [4 ]
Lege, I. [5 ]
机构：
[1] Klaipeda Univ Hosp, Dept Oncol, Klaipeda, Lithuania
[2] Lithuanian Univ Hlth Sci, Dept Pathol, Kaunas, Lithuania
[3] Natl Ctr Pathol, Dept Breast Pathol, Vilnius, Lithuania
[4] Klaipeda Univ Hosp, Dept Pathol, Klaipeda, Lithuania
[5] AstraZeneca, Balt Med & Regulatory Dept, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113843
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276 (PB-09
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [41] HER2-Low Breast Cancer: Current Landscape and Future Prospects
    Shirman, Yelena
    Lubovsky, Shlomit
    Shai, Ayelet
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 605 - 616
  • [42] Refining the definition of HER2-low class in invasive breast cancer
    Atallah, Nehal M.
    Toss, Michael S.
    Green, Andrew R.
    Mongan, Nigel P.
    Ball, Graham
    Rakha, Emad A.
    HISTOPATHOLOGY, 2022, 81 (06) : 770 - 785
  • [43] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Man Yang
    Jiale Sun
    Liqiong Liu
    Xiangyi Kong
    Dongcai Lin
    Hong Zhou
    Jidong Gao
    Scientific Reports, 13 (1)
  • [44] Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer
    Tarantino, Paolo
    ONCOLOGY-NEW YORK, 2023, 37 (12): : 496 - 501
  • [45] Clinical presentations and prognosis of HER2-low breast cancer in Taiwan
    Chen, G. Y-J
    Hsu, C-Y
    Huang, C-C
    Tseng, L-M
    ANNALS OF ONCOLOGY, 2024, 35 : S283 - S284
  • [46] Assessment of specificity of TiLs subpopulations in HER2-low breast cancer
    Telezhnikova, I.
    Eremeeva, E.
    Setdikova, G.
    VIRCHOWS ARCHIV, 2024, 485 : S207 - S207
  • [47] How I treat HER2-low advanced breast cancer
    Schlam, Ilana
    Tolaney, Sara M.
    Tarantino, Paolo
    BREAST, 2023, 67 : 116 - 123
  • [48] The dynamics of HER2-low expression during breast cancer progression
    Anderson, Sarah
    Bartow, Brooke Baxter
    Siegal, Gene P.
    Huang, Xiao
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 437 - 446
  • [49] HER2-low breast cancer: Novel detections and treatment advances
    Wu, Yun
    Zhong, Ruiqi
    Ma, Fei
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 181
  • [50] The dynamics of HER2-low expression during breast cancer progression
    Sarah Anderson
    Brooke Baxter Bartow
    Gene P. Siegal
    Xiao Huang
    Shi Wei
    Breast Cancer Research and Treatment, 2023, 201 : 437 - 446
12345